Spero Therapeutics

176 articles about Spero Therapeutics

• Spero Unveils Data On Lead Potentiator Candidate For The Treatment Of Multidrug Resistant Gram-Negative Infections At ASM Microbe 2016

  6/21/2016

• Spero To Unveil Data On Potentiator Platform At ASM Microbe 2016

  6/8/2016

• Spero Acquires Novel Gyrase Inhibitors From Vertex

  5/25/2016

• Spero To Present At The 15th Annual Needham Healthcare Conference

  4/5/2016

• Spero Hires Cristina Larkin As Chief Commercial Officer

  3/2/2016

• Spero To Present At Cowen and Company 36th Annual Health Care Conference

  2/29/2016

• 

  Top 20 Life Science Startups to Watch in the U.S.

  1/26/2016

  BioSpace is pleased to present its NextGen Bio “Class of 2016.” This list contains 20 life science companies that launched no earlier than 2013 and are headquartered in the United States.

• Spero Hires Former BARDA Anti-Infectives Program Chief

  1/19/2016

• Spero Licenses Dihydrofolate Reductase Inhibitors From Promiliad Biopharma To Enhance Anti-Infective Pipeline

  1/7/2016

• Evotec AG And Spero Extend Collaboration To Develop Novel Antibacterials

  12/15/2015

• What You Need to Know About Spero

  12/2/2015

• Spero Expands Leadership Team, Advisory Board With Industry Veterans

  9/17/2015

• Spero Achieves First Milestone Payment In Anti-Infective Partnership With Roche

  7/21/2015

• Merck & Co., New England Patriots Owner Wager $30 Million on Cambridge Startup, Spero

  6/9/2015

• Spero Appoints Thomas Parr, Ph.D. As Chief Scientific Officer

  5/20/2014

• Startup Spero Emerges With $3 Million, Backing From Roche

  4/9/2014